Thierry Lacaze-Masmonteil, University of Ottawa

Research

Cardiac Function Chronic Obstructive Pulmonary Disease Exercise Heart Failure Lung Health Physical Activity Prematurity Pulmonary Function

Latest papers

Time for a regulatory framework for pediatric medications in Canada
CANADIAN MEDICAL ASSOCIATION JOURNAL · 2022
Newborn Bilirubin Screening for Preventing Severe Hyperbilirubinemia and Bilirubin Encephalopathy: A Rapid Review.
Current Pediatric Reviews · 2017
Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial
PLoS ONE · 2017 · senior author

All 9 publications

Latest funding

Developing and implementing a core outcome set for adolescents and adults with phenylketonuria
CIHR · 2026 · Co-investigator
$539,325
An innovative registry-based trials platform to improve clinical care, outcomes, and health policy for children with treatable rare diseases
CIHR · 2019 · Co-investigator
$2,754,009
Effect of folic acid supplementation in pregnancy on preeclampsia
CIHR · 2015 · Co-investigator
$100,000

All 4 grants and awards

9 publications.

01

Time for a regulatory framework for pediatric medications in Canada

Gilpin A, Bérubé S, Moore-Hepburn C, Lacaze-Masmonteil T, Samiee-Zafarghandy S, Rieder M, Gruenwoldt E, MacLeod S, Litalien C

CANADIAN MEDICAL ASSOCIATION JOURNAL20228 citations

DOI: 10.1503/cmaj.220044

02

Newborn Bilirubin Screening for Preventing Severe Hyperbilirubinemia and Bilirubin Encephalopathy: A Rapid Review.

Bhardwaj K, Locke T, Biringer A, Booth A, Darling EK, Dougan S, Harrison J, Hill S, Johnson A, Makin S

Current Pediatric Reviews201732 citations

DOI: 10.2174/1573396313666170110144345

03

Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial

Lemyre B, Fusch C, Schmölzer GM, Bouali NR, Reddy D, Barrowman N, Huneault-Purney N, Lacaze-Masmonteil T

PLoS ONE201718 citationsSenior authorOpen Access

DOI: 10.1371/journal.pone.0175922 PMID: W2611657032

04

A Randomized Controlled Trial of Innovative Postpartum Care Model for Mother-Baby Dyads.

Laliberté C, Dunn S, Pound C, Sourial N, Yasseen AS, Millar D, Rennicks White R, Walker M, Lacaze-Masmonteil T

PloS one2016Senior author

DOI: 10.1371/journal.pone.0148520 PMID: 26871448

05

A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.

Bialy L, Vandermeer B, Lacaze-Masmonteil T, Dryden DM, Hartling L

Evidence-based child health : a Cochrane review journal2014

DOI: 10.1002/ebch.1985 PMID: 25504975

06

Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review.

Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I

Pediatrics2014

DOI: 10.1542/peds.2014-0459 PMID: 24913791

07

That chorioamnionitis is a risk factor for bronchopulmonary dysplasia--the case against.

Lacaze-Masmonteil T

Paediatric respiratory reviews2014First author

DOI: 10.1016/j.prrv.2013.09.005 PMID: 24120077

08

Value of a single C-reactive protein measurement at 18 h of age.

Lacaze-Masmonteil T, Rosychuk RJ, Robinson JL

Archives of disease in childhood. Fetal and neonatal edition2014First author

DOI: 10.1136/archdischild-2013-303984 PMID: 24008814

09

Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis.

Hartling L, Liang Y, Lacaze-Masmonteil T

Archives of disease in childhood. Fetal and neonatal edition2012Senior author

DOI: 10.1136/adc.2010.210187 PMID: 21697236

Developing and implementing a core outcome set for adolescents and adults with phenylketonuria

Co-investigatorCIHR2026Project Grant

Principal investigators: Potter, Elizabeth K; Mitchell, John J; Nimmo, Graeme; Pender, Amy; Smith, Maureen M

Keywords: Adolescents; Adults; Clinical Research; Core Outcome Set; Outcomes; Phenylketonuria; Rare Disease; Transition To Adult Care

$539,325

An innovative registry-based trials platform to improve clinical care, outcomes, and health policy for children with treatable rare diseases

Co-investigatorCIHR2019Operating Grant: SPOR Innovative Clinical Trial Multi-Year Grant

Principal investigators: Potter, Elizabeth K; McCabe, Christopher; Smith, Maureen M; Binik, Ariella; Chakraborty, Pranesh K; Inbar-Feigenberg, Michal; Mitchell, John J; Offringa, Martin; Oskoui, Maryam; Stockler, Sylvia

Keywords: Comparative Effectiveness; Core Outcomes; Genetic Disease; Innovative Clinical Trial; Orphan Therapy; Patient Partnership; Patient-Oriented Outcomes; Pediatrics; Rare Disease; Registry-Based Randomized Trial

$2,754,009

Effect of folic acid supplementation in pregnancy on preeclampsia

Co-investigatorCIHR2015Operating Grant

Principal investigators: Wen, Shi Wu; Fraser, William D; Walker, Mark C

Keywords: Folic Acid Supplementation; Preeclampsia; Pregnancy; Randomized Controlled Trial

$100,000

Long-term Cardio-Respiratory Outcomes of Extremely Pre-term Infants: A Workshop to Guide Development of a Current Canadian Study

Principal investigatorCIHR2013Planning Grants - PA: Integrated health services, Developmental Origins of hlth

Principal investigators: Katz, Sherri L; Stevens Lavigne, Andrea L; Lacaze-Masmonteil, Thierry; Thebaud, Bernard

Keywords: Cardiac Function; Chronic Obstructive Pulmonary Disease; Exercise; Heart Failure; Lung Health; Physical Activity; Prematurity; Pulmonary Function; Pulmonary Hypertension; Pulmonary Imaging

$24,973

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Mark Walker and Julian Little: 13 shared papers
Sandra Dunn and Mark Walker: 7 shared papers
Julian Little and Beth Potter: 6 shared papers
Sandra Dunn and Brigitte Lemyre: 5 shared papers
Thierry Lacaze-Masmonteil and Thierry Lacaze-Masmonteil: 5 shared papers
Thierry Lacaze-Masmonteil and Brigitte Lemyre: 5 shared papers
Samira Samiee-Zafarghandy and Christoph Fusch: 4 shared papers
Mark Walker and Beth Potter: 4 shared papers
Isabelle Marc and Thierry Lacaze-Masmonteil: 4 shared papers
Isabelle Marc and Brigitte Lemyre: 4 shared papers
Brigitte Lemyre and Nicholas Barrowman: 4 shared papers
Liz Darling and Mark Walker: 3 shared papers
Liz Darling and Sandra Dunn: 2 shared papers
Liz Darling and Julian Little: 2 shared papers
Samira Samiee-Zafarghandy and Thierry Lacaze-Masmonteil: 2 shared papers
Brigitte Lemyre and Nicole Rouvinez-Bouali: 2 shared papers
Liz Darling and Stephen Hill: 1 shared paper
Liz Darling and Ana Johnson: 1 shared paper
Liz Darling and Thierry Lacaze-Masmonteil: 1 shared paper
Liz Darling and Beth Potter: 1 shared paper
Samira Samiee-Zafarghandy and Michael Rieder: 1 shared paper
Samira Samiee-Zafarghandy and Thierry Lacaze-Masmonteil: 1 shared paper
Samira Samiee-Zafarghandy and Thierry Lacaze-Masmonteil: 1 shared paper
Samira Samiee-Zafarghandy and Thierry Lacaze-Masmonteil: 1 shared paper
Samira Samiee-Zafarghandy and Thierry Lacaze-Masmonteil: 1 shared paper
Samira Samiee-Zafarghandy and Thierry Lacaze-Masmonteil: 1 shared paper
Christoph Fusch and Thierry Lacaze-Masmonteil: 1 shared paper
Christoph Fusch and Brigitte Lemyre: 1 shared paper
Christoph Fusch and Nicholas Barrowman: 1 shared paper
Christoph Fusch and Nicole Rouvinez-Bouali: 1 shared paper
Stephen Hill and Ana Johnson: 1 shared paper
Stephen Hill and Thierry Lacaze-Masmonteil: 1 shared paper
Ana Johnson and Thierry Lacaze-Masmonteil: 1 shared paper
Michael Rieder and Thierry Lacaze-Masmonteil: 1 shared paper
Michael Rieder and Thierry Lacaze-Masmonteil: 1 shared paper
Michael Rieder and Thierry Lacaze-Masmonteil: 1 shared paper
Michael Rieder and Thierry Lacaze-Masmonteil: 1 shared paper
Michael Rieder and Thierry Lacaze-Masmonteil: 1 shared paper
Catherine Pound and Sandra Dunn: 1 shared paper
Catherine Pound and Mark Walker: 1 shared paper
Catherine Pound and Thierry Lacaze-Masmonteil: 1 shared paper
Sandra Dunn and Thierry Lacaze-Masmonteil: 1 shared paper
Mark Walker and Thierry Lacaze-Masmonteil: 1 shared paper
Thierry Lacaze-Masmonteil and Isabelle Marc: 1 shared paper
Thierry Lacaze-Masmonteil and Julian Little: 1 shared paper
Thierry Lacaze-Masmonteil and Thierry Lacaze-Masmonteil: 1 shared paper
Thierry Lacaze-Masmonteil and Thierry Lacaze-Masmonteil: 1 shared paper
Thierry Lacaze-Masmonteil and Thierry Lacaze-Masmonteil: 1 shared paper
Thierry Lacaze-Masmonteil and Thierry Lacaze-Masmonteil: 1 shared paper
Thierry Lacaze-Masmonteil and Marc Rhainds: 1 shared paper
Thierry Lacaze-Masmonteil and Thierry Lacaze-Masmonteil: 1 shared paper
Thierry Lacaze-Masmonteil and Beth Potter: 1 shared paper
Thierry Lacaze-Masmonteil and Brigitte Lemyre: 1 shared paper
Thierry Lacaze-Masmonteil and Nicholas Barrowman: 1 shared paper
Thierry Lacaze-Masmonteil and Nicole Rouvinez-Bouali: 1 shared paper
Isabelle Marc and Marc Rhainds: 1 shared paper

Pediatrics
School of Epidemiology and Public Health
Obstetrics and Gynecology
Pediatric Respirology
Public Health Sciences
Obstetrics & Gynecology
Pathology & Molecular Medicine
Other

1 shared papers, latest 2016

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Cardiac Function Dear Professor Lacaze-Masmonteil, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Time for a regulatory framework for pediatric medications in Canada" (2022), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]